Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 81-90 of 287 for Lung cancer

Edit search filters
  1. Combination Therapies With Adagrasib In Patients With Advanced NSCLC With KRAS G12C Mutation

    Jacksonville, FL, Rochester, MN

  2. A Study Of BH-30643 In Subjects With Locally Advanced Or Metastatic NSCLC Harboring EGFR And/or HER2 Mutations

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. A Study Of Poziotinib In Patients With NSCLC With EGFR Or HER2 Exon 20 Insertion Mutation

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study To Evaluate Firstline Pembrolizumab Alone Or In Combination With Pemetrexed And Carboplatin In Induction/Maintenance Or Postprogression In Treating Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

    Albert Lea, MN, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  5. Fasting Mimicking Diet For Reducing Immune Related Adverse Events For Cancer Patients On Immune Checkpoint Inhibitors, FMD-ICI Trial

    Jacksonville, FL

  6. A Study To Evaluate Testing The Addition Of Targeted Radiation Therapy To Surgery And The Usual Chemotherapy Treatment For Stage I-IIIA Malignant Pleural Mesothelioma

    Rochester, MN

  7. Study Of VS-6766 + Adagrasib In KRAS G12C NSCLC Patients

    Jacksonville, FL, Rochester, MN

  8. Clinical Study Of Ivonescimab For First-line Treatment Of Metastatic NSCLC Patients

    Jacksonville, FL, Rochester, MN

  9. Study Of Durvalumab + Tremelimumab With Chemotherapy Or Durvalumab With Chemotherapy Or Chemotherapy Alone For Patients With Lung Cancer (POSEIDON).

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  10. Effect Of TTFields (150 KHz) In Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS)

    Scottsdale/Phoenix, AZ, Jacksonville, FL

.

Mayo Clinic Footer